ABO-incompatible kidney transplantation in The Netherlands.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON27246

Enrollment

10000

Registered

2019-03-05

Start date

2019-03-05

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

kidney transplantation

Interventions

This is an observational study.

Eligibility

Inclusion criteria

Inclusion criteria: 1. ABO-incomaptible and ABO-compatible kidney transplantations performed between March 2006 and January 2018. 2. CNI-based immunosuppresive therapy

Exclusion criteria

Exclusion criteria: 1. unknown maintenance immunosuppresive therapy. 2. age <16 years 3. unknown ABO status

Design outcomes

Secondary

Measure	Time frame
Secondary outcomes include: - Patient survival - Renal function and proteinuria - Infection - Non-skin malignancy - Renal allograft rejection - Comparison with kidney transplant recipient with a postmortal allograft - Comparison with kidney transplant recipients which an ABO-compatible donor via the national kidney exchange program	—

Primary

Measure	Time frame
The primary outcome is (uncensored) graft survival of ABO-incompatible kidney transplant recipients as compared to ABO-compatible control patients with a living donor.	—

Contacts

Public ContactAnnelies de Weerd

Erasmus Medical Center

a.deweerd@erasmusmc.nl0618834197

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)